Clinical Trial Update: A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma [Phase 2]

View source ↗

Summary

This document provides a status update on a Phase 2 trial evaluating lifileucel (tumor-infiltrating lymphocytes) in adults with advanced melanoma, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Lifileucel (autologous tumor-infiltrating lymphocytes (TIL) therapy)

Snippet

Sponsor: Iovance Biotherapeutics, Inc. | Conditions: Melanoma (Skin Cancer), Unresectable Melanoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING